CompletedNot Applicable

Impact of Acquired FXIII Deficiency on Morbidity and Mortality

Spain50 participantsStarted 2019-09-10

Plain-language summary

Observational prospective study aiming to assess acquired FXIII deficiency implications in morbidity and mortality

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * FXIII levels \< 70% Exclusion Criteria: * None

Cut-Point levels of FXIII

Timeframe: 2 years

NCT IDNCT04416594

SponsorPatricia Duque González

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-02-12